CN108498770A - A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid - Google Patents
A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid Download PDFInfo
- Publication number
- CN108498770A CN108498770A CN201810502728.2A CN201810502728A CN108498770A CN 108498770 A CN108498770 A CN 108498770A CN 201810502728 A CN201810502728 A CN 201810502728A CN 108498770 A CN108498770 A CN 108498770A
- Authority
- CN
- China
- Prior art keywords
- parts
- rheumatoid
- rhizoma
- root
- crude drugs
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/714—Aconitum (monkshood)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/11—Pteridophyta or Filicophyta (ferns)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/237—Notopterygium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/51—Gentianaceae (Gentian family)
- A61K36/515—Gentiana
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/716—Clematis (leather flower)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physical Education & Sports Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid, are made of the component of following parts by weight：Tag processed：46 parts；Rhizoma zingiberis：8 12 parts；Cassia twig：8 12 parts；Radix Angelicae Pubescentis：18 22 parts；Rhizoma Et Radix Notopterygii：14 16 parts；Bark of ash：8 12 parts；The root of bidentate achyranthes：8 12 parts；The root of Chinese clematis：8 12 parts；Rhizoma homalonemae：14 16 parts；Lycopodium calvatum：14 16 parts.It is provided by the invention it is a kind for the treatment of serious rheumatism, the Chinese herbal and crude drugs preparations of rheumatoid carry out complex treatment for this disease of rheumathritis, rheumatoid arthritis, thorough treatment, therapeutic effect is good.
Description
Technical field
The present invention relates to preparations, and in particular to a kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid.
Background technology
Serious orthopaedic disease such as rheumatism, rheumatoid movement disorders seriously threaten the health of the mankind, and illness can seriously cause
Disability can't take care of oneself, more frighteningly Principle of Pain unbearably, agony.The drug in market is substantially invalid, letter
What single antalgica do not play, and the drug list in terms of Chinese medicine makes (or single dosage form) drug, and effect is bad, because this kind of
Disease persistent ailment can not possibly a kind of pharmaceutical formulation can work, along with the unreasonable drug development management method in China, indulge in
It has missed " serious disease " to have to move " generous " treatment, the generated preparation of a formula, that is, a kind of drug, " small monarch can only be
Minister assistant makes ", the drug of different formulations, different dosage forms cooperates with jointly, and outer attack for oral administration can just capture these rheumatisms, this side
Method is " big monarch " method.Present television advertising products propaganda can control rheumatism, rheumatoid, actually effect and bad.
Present market, hospital, the serious rheumatism that pharmacy is sold, rheumatism medicine be all single formulation, it is impossible to
These persistent ailments are treated, as making a call to a fierce tiger, a people can beatIt cannot not only beat, but also to be eaten up by tiger.With one kind
This persistent ailment of drug treatment of dosage form, not only controls bad, can miss the time instead, and the application is for serious rheumatism, rheumatoid
Persistent ailment, we just should according to the rule that Chinese medicine is cured the disease, to organize the drug of this " big monarch " different dosage forms, never
Serious rheumatism, the chill of rheumatoid, Shi, Paralysis are thoroughly excluded human body, done by same application method, oral granddad, collaboration medication
To therapeutic effect.Rather than buy the capsule of this medicine today, tomorrow buys the ointment of that, will buy the medicinal liquor of another family the day after tomorrow, these
Different manufacturers, different pharmacy, different medicines I not only ununified therapeutic scheme but also there is no the guidance of doctor expert, added
The side effect and drug reciprocity law that drug abuse generates, the good disease of this treatment, this development for pushing traditional Chinese medicine.
Invention content
In view of the deficiencies in the prior art, the purpose of the present invention is to provide a kind of drugs of different dosage forms, never
Human body is thoroughly discharged in serious rheumatism, the chill of rheumatoid, wet, numbness by same application method, oral external application, collaboration medication, is reached
To therapeutic effect.
To achieve the above objectives, the technical solution adopted by the present invention is that：
A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid, are made of the component of following parts by weight：Tag processed：
4-6 parts；Rhizoma zingiberis：8-12 parts；Cassia twig：8-12 parts；Radix Angelicae Pubescentis：18-22 parts；Rhizoma Et Radix Notopterygii：14-16 parts；Bark of ash：8-12 parts；The root of bidentate achyranthes：8-12
Part；The root of Chinese clematis：8-12 parts；Rhizoma homalonemae：14-16 parts；Lycopodium calvatum：14-16 parts.
Based on the above technical solution, the preparation is made of the component of following parts by weight：Tag processed：5 parts；It is dry
Ginger：10 parts；Cassia twig：10 parts；Radix Angelicae Pubescentis：20 parts；Rhizoma Et Radix Notopterygii：15 parts；Bark of ash：10 parts；The root of bidentate achyranthes：10 parts；The root of Chinese clematis：10 parts；Rhizoma homalonemae：
15 parts；Lycopodium calvatum：15 parts.
A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid of the present invention are for rheumathritis, rheumatoid
This disease progress complex treatment of arthritis, thorough treatment, therapeutic effect are good.
Specific implementation mode
Invention is further described in detail below.
It is provided by the invention it is a kind of treat serious rheumatism, rheumatoid Chinese herbal and crude drugs preparations by following parts by weight component system
At：Tag processed：4-6 parts；Rhizoma zingiberis：8-12 parts；Cassia twig：8-12 parts；Radix Angelicae Pubescentis：18-22 parts；Rhizoma Et Radix Notopterygii：14-16 parts；Bark of ash：8-12
Part；The root of bidentate achyranthes：8-12 parts；The root of Chinese clematis：8-12 parts；Rhizoma homalonemae：14-16 parts；Lycopodium calvatum：14-16 parts.
In the present invention, above-mentioned 10 taste concentration is that extract dry is processed as the general piller of water, divides 60 days and takes, 2-3 times daily.System
Tag category drugs for dispelling internal cold, nature and flavor great Xin, big heat are toxic, there is recuperating depleted yang, tonifying spleen and kidney, eliminating cold to stop pain, Wen Yang by it is cold the effect of；
Cassia twig is the dry twig of canella Chinese cassia tree, is generally harvested in spring, summer, goes directly to dry or be sliced after disleaf to dry i.e.
Can, cassia twig pungent-warm, can cold-dispelling, cold, fever with chilliness etc. can be treated；Rhizoma Et Radix Notopterygii is Umbelliferae, Notopterygium perennial herb
Plant, rhizome and root are medicinal, warm-natured, dispellieg cold and dampness, for catching cold, headache and adiapneustia, cold-dampness numbness, upper limb rheumatalgia pain；Bark of ash
Alias：Gentiana macrophylla, great Ye bark of ash, RADIX GENTIANAE MACROPHYLLAE, there is high medical value, be treatment rheumatic arthritis, tuberculosis, hectic fever,
One of main ingredients of diseases such as jaundice；The root of bidentate achyranthes, alias ox knock knee, and root is used as medicine, raw to use, invigorate blood circulation；Clematis root and stem are used as medicine and have
The effect of wind-damp dispelling, degrading the channel, the bone that disappears stalk；Rhizoma homalonemae is the dry rhizome of aroid rhizoma homalonemae, is adopted in spring, two season of autumn
It digs, cleans, crust is removed, the effect of drying, have wind-damp dispelling, strengthen the bone；Lycopodium calvatum is the drying herb of lycopsid lycopod,
Summer, two season of autumn cauline leaf it is luxuriant when harvest, remove impurity, dry, there is the effect of dispelling wind and eliminating dampness, relaxing tendons and activating collaterals.
The present invention key point aiming at rheumathritis, the complex treatment of this disease of rheumatoid arthritis, and this
Kind complex treatment " big monarch " oral administration and externally preparation uses simultaneously, disease cannot be allowed to have off time, it is necessary to from human body machine
Internal portion is all discharged wind-cold-dampness arthralgia.In externally applied drug to the marrow, the disease that joint for many years deposits is removed by inside and outside press hard, allows bone
The blood circulation in head channels and collaterals joint, supplies oxygen nutriment.This method, which is cured the disease, actually implements what large troop formation besieged
The dosage of mode, drug uses simultaneously, based on nontoxic drug sustained oral, based on toxic pharmaceuticals external application, will not injure human body but
It works to wind-cold-dampness arthralgia.If in this way, I am not with single preparation for treating, the foundation of disease is not moved, disease will
It is as stable as Mount Tai, exist for a long time in human synovial, cause stasis, the normal operation for hindering metabolism grows other diseases
Disease, dysarthrasis lose freedom of action when serious.
It is five specific embodiments of the present invention below：
Embodiment one：
It is a kind for the treatment of serious rheumatism, the Chinese herbal and crude drugs preparations of rheumatoid are made of the component of following parts by weight：
Tag processed：5 parts；Rhizoma zingiberis：10 parts；Cassia twig：10 parts；Radix Angelicae Pubescentis：20 parts；Rhizoma Et Radix Notopterygii：15 parts；Bark of ash：10 parts；The root of bidentate achyranthes：10
Part；The root of Chinese clematis：10 parts；Rhizoma homalonemae：15 parts；Lycopodium calvatum：15 parts.
The effect of the present embodiment is most highly preferred embodiment of the invention, and the proportioning of each component is reasonable, each component can obtain most
Big performance.
Embodiment two：
It is a kind for the treatment of serious rheumatism, the Chinese herbal and crude drugs preparations of rheumatoid are made of the component of following parts by weight：
Tag processed：4 parts；Rhizoma zingiberis：8 parts；Cassia twig：12 parts；Radix Angelicae Pubescentis：22 parts；Rhizoma Et Radix Notopterygii：16 parts；Bark of ash：12 parts；The root of bidentate achyranthes：8 parts；
The root of Chinese clematis：12 parts；Rhizoma homalonemae：16 parts；Lycopodium calvatum：14 parts.
Embodiment three：
It is a kind for the treatment of serious rheumatism, the Chinese herbal and crude drugs preparations of rheumatoid are made of the component of following parts by weight：
Tag processed：6 parts；Rhizoma zingiberis：12 parts；Cassia twig：8 parts；Radix Angelicae Pubescentis：18 parts；Rhizoma Et Radix Notopterygii：14 parts；Bark of ash：8 parts；The root of bidentate achyranthes：12 parts；
The root of Chinese clematis：8 parts；Rhizoma homalonemae：14 parts；Lycopodium calvatum：16 parts.
Example IV：
It is a kind for the treatment of serious rheumatism, the Chinese herbal and crude drugs preparations of rheumatoid are made of the component of following parts by weight：
Tag processed：5 parts；Rhizoma zingiberis：9 parts；Cassia twig：11 parts；Radix Angelicae Pubescentis：19 parts；Rhizoma Et Radix Notopterygii：14 parts；Bark of ash：11 parts；The root of bidentate achyranthes：10
Part；The root of Chinese clematis：12 parts；Rhizoma homalonemae：15 parts；Lycopodium calvatum：15 parts.
Embodiment five：
It is a kind for the treatment of serious rheumatism, the Chinese herbal and crude drugs preparations of rheumatoid are made of the component of following parts by weight：
Tag processed：6 parts；Rhizoma zingiberis：8 parts；Cassia twig：8 parts；Radix Angelicae Pubescentis：21 parts；Rhizoma Et Radix Notopterygii：14 parts；Bark of ash：9 parts；The root of bidentate achyranthes：11 parts；
The root of Chinese clematis：10 parts；Rhizoma homalonemae：15 parts；Lycopodium calvatum：16 parts.
The advantage of the invention is that having used traditional core theory of Chinese traditional Chinese medicine, organic conception, having effected a permanent cure and take stopgap measures, is " same
Disease different is controlled " all while considering with " treating different diseases with same method ", strengthening vital QI to eliminate pathogenic factors, by the cold sick medicine of a warm nature, Medicine for the treatment of rheumatism and arthritis, blood circulation and stasis-eliminating medicine,
The disease complete liquidation of formation rheumatism, rheumatoid is gone out external joint, channels and collaterals by relaxing tendons and activating collaterals medicine collective effect, allows these devices of human body
Official gains freedom, blood flow, metabolism restore, and disease has not existed naturally, and human body obtains health, and here it is the present invention's
Essential purpose cannot allow the disease of serious rheumathritis, rheumatoid arthritis these self-assembling formations to be endangered in the world
The mankind.
The above described is only a preferred embodiment of the present invention, being not that the invention has other forms of limitations, appoint
What those skilled in the art changed or be modified as possibly also with the technology contents of the disclosure above equivalent variations etc.
Imitate embodiment.In every case it is to be made according to the technical essence of the invention to above example without departing from technical solution of the present invention content
Any simple modification, equivalent variations and remodeling, still fall within the protection domain of technical solution of the present invention.
The content not being described in detail in this specification belongs to the prior art well known to professional and technical personnel in the field.
Claims (2)
1. a kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid, which is characterized in that by the component system of following parts by weight
At：
Tag processed：4-6 parts；Rhizoma zingiberis：8-12 parts；Cassia twig：8-12 parts；Radix Angelicae Pubescentis：18-22 parts；Rhizoma Et Radix Notopterygii：14-16 parts；Bark of ash：8-12
Part；The root of bidentate achyranthes：8-12 parts；The root of Chinese clematis：8-12 parts；Rhizoma homalonemae：14-16 parts；Lycopodium calvatum：14-16 parts.
2. a kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid as described in claim 1, it is characterised in that：By following
The component of parts by weight is made：
Tag processed：5 parts；Rhizoma zingiberis：10 parts；Cassia twig：10 parts；Radix Angelicae Pubescentis：20 parts；Rhizoma Et Radix Notopterygii：15 parts；Bark of ash：10 parts；The root of bidentate achyranthes：10 parts；Prestige
Medicine xiaolingxian：10 parts；Rhizoma homalonemae：15 parts；Lycopodium calvatum：15 parts.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810502728.2A CN108498770A (en) | 2018-05-23 | 2018-05-23 | A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810502728.2A CN108498770A (en) | 2018-05-23 | 2018-05-23 | A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108498770A true CN108498770A (en) | 2018-09-07 |
Family
ID=63401165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810502728.2A Pending CN108498770A (en) | 2018-05-23 | 2018-05-23 | A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108498770A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1964730A (en) * | 2004-06-09 | 2007-05-16 | 深圳市前仁人科技开发有限公司 | Herbal compositions for prevention and treatment rheumatic and inflammatory diseases and method of preparing the same |
| CN101954045A (en) * | 2010-09-20 | 2011-01-26 | 广州博济新药临床研究中心有限公司 | Traditional Chinese medicinal composition for treating damp arthralgia and preparation method thereof |
-
2018
- 2018-05-23 CN CN201810502728.2A patent/CN108498770A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1964730A (en) * | 2004-06-09 | 2007-05-16 | 深圳市前仁人科技开发有限公司 | Herbal compositions for prevention and treatment rheumatic and inflammatory diseases and method of preparing the same |
| CN101954045A (en) * | 2010-09-20 | 2011-01-26 | 广州博济新药临床研究中心有限公司 | Traditional Chinese medicinal composition for treating damp arthralgia and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 孙观荣: "李茂才治疗类风湿性关节炎经验", 《浙江中医杂志》 * |
| 林朝海: "综合治疗类风湿性关节炎38例", 《湖南中医杂志》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102225102A (en) | Medicinal liquor for treating rheumatoid arthritis | |
| CN103027195A (en) | Anticoccidial traditional Chinese medicinal feed additive | |
| CN106038934A (en) | Traditional Chinese medicine disinfectant for acupuncture | |
| CN102247519A (en) | Formula of traditional Chinese medicine for treating rheumatoid arthritis | |
| CN101129697A (en) | Orally taken traditional Chinese medicine composition for treating atrophic arthritis | |
| CN104721480B (en) | Treat Chinese herbal medicine for external use composition of traumatic injury and its preparation method and application | |
| CN108498770A (en) | A kind of Chinese herbal and crude drugs preparations for treating serious rheumatism, rheumatoid | |
| CN101214353B (en) | Medicament for treating chicken myeloencephalitis | |
| CN103705556B (en) | One treats tetanic Chinese medicine composition | |
| CN104857089B (en) | A kind of decoction for treating rheumatism and rheumatoid arthritis and preparation method thereof | |
| CN103520501B (en) | External use medicine for treating ostealgia disease | |
| CN107510765A (en) | A kind of Chinese medicine composition for treating phlegm-blood stasis numbness network type rheumatic Bi syndrome and preparation method thereof | |
| WO2018176642A1 (en) | Chinese medicine for treating skin inflammation | |
| CN107213224A (en) | A kind of wine for relaxing muscles and tendons | |
| CN107335025A (en) | It is a kind of to be used to treat Chinese medicine composition of rheumatism and preparation method thereof | |
| CN1286113A (en) | Medical capsule for treating rheumatism and building up body and its preparing process | |
| CN101095806A (en) | Chinese medicine preparation for treating diabetes skin pruritus | |
| CN105560427A (en) | Transdermal gate-freeing powder | |
| CN105412395A (en) | Traditional Chinese medicine composition for treating hyperostosis and preparation method thereof | |
| CN104971209A (en) | Externally used agent for treating tinea pedis and preparation method thereof | |
| CN105012709B (en) | For the positive ball of kidney tonifying temperature of flaccid paralysis | |
| CN104922266A (en) | Antibacterial fluid for treating onychomycosis and tinea of feet and hands, and preparation method thereof | |
| CN103156940B (en) | A kind of extracting technique of Chinese medicine for garden balsam stem pain-relieving | |
| CN103157081A (en) | Medicament for relaxing tendons and activating collaterals | |
| CN109481553A (en) | Logical numbness SHUJIN WAN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20180907 |